Pharm-Olam and CATO-SMS have merged. Learn More
Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
“Adaptive designs” in clinical research refer to study designs where certain features are left flexible on purpose, so they...
The ongoing COVID-19 pandemic has brought into focus the impact that respiratory viral infections have on the health and...
Microbiome and microbiota are attracting an increasing amount of attention in the world of medical research (click here for a...
Tags: Pharm-Olam Insights, Autoimmune
Location plays a critical role in many studies, but the impact of geography has a significant impact in allergy and asthma...
Tags: Pharm-Olam Insights, Allergy & Immunology, CRO Services
Site location can have a significant impact on clinical trial success. Study protocols often have established timelines and...
COVID-19 moved from a ubiquitous virus to a full-on pandemic very quickly. As countries and city centers took steps to stem...
The onset of the COVID-19 pandemic has introduced a variety of challenges to “business as usual.” The virus and the ensuing...
Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, COVID-19
Managing the COVID-19 pandemic has prompted countries and regions around the world to introduce a series of adaptions. For the...
Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, COVID-19
Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
